相似文献
1
Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.胎儿和新生儿溶血病的预防与治疗建议。
Blood Transfus. 2015 Jan;13(1):109-34. doi: 10.2450/2014.0119-14.
2
Rh haemolytic disease of the newborn: the role of the laboratory.
Med Lab Sci. 1982 Jul;39(3):297-303.
3
[Haemolytic disease of the newborn (fetus) (author's transl)].新生儿（胎儿）溶血病（作者译）
Immun Infekt. 1976 Dec;4(6):249-60.
4
The prevention of haemolytic disease of the newborn.
Ir J Med Sci. 1967 Jun;6(498):276-80.
5
Amniocentesis in erythroblastosis fetalis.
Md State Med J. 1966 Sep;15(9):115-7.
6
[Work of the maternity hospital No. 23 specializing in the prevention and treatment of hemolytic disease of newborn].
Akush Ginekol (Mosk). 1974 Nov(11):50-4.
7
[ABO incompatibility and newborn haemolytic disease: two cases with major erythroblastosis].[ABO血型不合与新生儿溶血病：两例重度成红细胞增多症病例]
Ann Biol Clin (Paris). 2004 May-Jun;62(3):344-8.
8
Rhesus haemolytic disease; an approach to prevention.
Nurs Times. 1965 Sep 17;61(38):1267-9.
9
Prevention of haemolytic disease of the newborn by the administration of anti-D to the mother.
Ger Med Mon. 1969 Feb;14(2):58-62.
10
Prevention of rhesus haemolytic disease of the fetus and newborn.
Lancet. 2009 Mar 28;373(9669):1082. doi: 10.1016/S0140-6736(09)60651-6.
引用本文的文献
1
HPLC and flow cytometry combined approach for HbF analysis in fetomaternal haemorrhage evaluation.高效液相色谱法与流式细胞术联合用于胎儿-母体出血评估中血红蛋白F分析的方法
Pract Lab Med. 2024 May 16;40:e00401. doi: 10.1016/j.plabm.2024.e00401. eCollection 2024 May.
2
Misclassification of RhD variants among pregnant women: a systematic review.孕妇 RhD 变异型的错误分类：系统评价。
J Med Life. 2023 Jul;16(7):981-989. doi: 10.25122/jml-2023-0004.
3
Early Hyporegenerative Anemia Complicating Hemolytic Disease of the Newborn Secondary to Rhesus Alloimmunization.由恒河猴同种免疫引起的新生儿溶血病并发早期再生低下性贫血
Cureus. 2021 Nov 15;13(11):e19603. doi: 10.7759/cureus.19603. eCollection 2021 Nov.
4
Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.由 Rh(D) 不相容引起的胎儿和新生儿溶血病：一种可预防的疾病，但仍会导致儿童出现严重的发病率和死亡率。
PLoS One. 2020 Jul 20;15(7):e0235807. doi: 10.1371/journal.pone.0235807. eCollection 2020.
5
Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial.重组抗D预防母婴Rh（D）血型不合免疫：一项随机多中心临床试验。
Obstet Gynecol Sci. 2020 May;63(3):315-322. doi: 10.5468/ogs.2020.63.3.315. Epub 2020 Apr 21.
6
The contribution of iron deficiency to the risk of peripartum transfusion: a retrospective case control study.缺铁对围产期输血风险的影响：一项回顾性病例对照研究。
BMC Pregnancy Childbirth. 2020 Apr 6;20(1):196. doi: 10.1186/s12884-020-02886-z.
7
Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question.恒河猴溶血性疾病的再生障碍性贫血及其他并发症：治疗与否是个问题。
Pan Afr Med J. 2019 Mar 14;32:120. doi: 10.11604/pamj.2019.32.120.17757. eCollection 2019.
8
Frequency of Red Cell Alloantibodies in Pregnant Females of Navsari District: An Experience that Favours Inclusion of Screening for Irregular Erythrocyte Antibody in Routine Antenatal Testing Profile.纳夫萨里地区孕妇红细胞同种抗体的频率：支持在常规产前检查项目中纳入不规则红细胞抗体筛查的经验。
J Obstet Gynaecol India. 2018 Aug;68(4):300-305. doi: 10.1007/s13224-017-0984-5. Epub 2017 Mar 29.
9
Anti-D Antibodies in Pregnant D Variant Antigen Carriers Initially Typed as RhD.最初血型鉴定为RhD的妊娠D变异抗原携带者中的抗-D抗体
Transfus Med Hemother. 2016 Nov;43(6):419-424. doi: 10.1159/000446816. Epub 2016 Oct 14.
本文引用的文献
1
BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn.英国血液学标准委员会关于使用抗-D免疫球蛋白预防胎儿和新生儿溶血病的指南。
Transfus Med. 2014 Feb;24(1):8-20. doi: 10.1111/tme.12091.
2
Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.意大利新生儿溶血病的预防与发病率调查。
Blood Transfus. 2013 Oct;11(4):518-27. doi: 10.2450/2013.0179-12. Epub 2013 Jun 14.
3
Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.妊娠期间 RhD 免疫的后果，以及如何优化新的预防策略。
Acta Obstet Gynecol Scand. 2013 Sep;92(9):1079-85. doi: 10.1111/aogs.12193. Epub 2013 Jul 5.
4
Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.自然流产后给予抗-D预防恒河猴同种免疫。
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD009617. doi: 10.1002/14651858.CD009617.pub2.
5
Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.孕期注射抗-D预防恒河猴血型同种免疫。
Cochrane Database Syst Rev. 2013 Feb 28(2):CD000020. doi: 10.1002/14651858.CD000020.pub2.
6
Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.孕期肌内注射与静脉注射抗D预防恒河猴同种免疫反应的比较。
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD007885. doi: 10.1002/14651858.CD007885.pub2.
7
Variants of RhD--current testing and clinical consequences.RhD 血型变体——当前的检测及临床意义。
Br J Haematol. 2013 May;161(4):461-70. doi: 10.1111/bjh.12275. Epub 2013 Feb 25.
8
A simple approach to confirm the presence of anti-D in sera with presumed anti-D+C specificity.一种用于确认具有假定抗-D+C特异性的血清中抗-D存在的简单方法。
Blood Transfus. 2013 Jul;11(3):449-51. doi: 10.2450/2012.0192-12. Epub 2013 Jan 23.
9
Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology.输血实验室输血前相容性检测程序指南。英国血液学标准委员会。
Transfus Med. 2013 Feb;23(1):3-35. doi: 10.1111/j.1365-3148.2012.01199.x. Epub 2012 Dec 6.
10
Therapeutic management of fetal anemia: review of standard practice and alternative treatment options.胎儿贫血的治疗管理：标准实践与替代治疗方案的回顾。
J Perinat Med. 2013 Jan;41(1):71-82. doi: 10.1515/jpm-2012-0093.
Zotero 插件